Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Piotroski F-Score
8 (As of Today)

Good Sign:

Piotroski F-Score of 8 is 8, indicating very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Teva Pharmaceutical Industries Ltd has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

TEVA' s 10-Year Piotroski F-Score Range
Min: 3   Max: 8
Current: 8

3
8

During the past 13 years, the highest Piotroski F-Score of Teva Pharmaceutical Industries Ltd was 8. The lowest was 3. And the median was 6.


Definition

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Jun14) TTM:Last Year (Jun13) TTM:
Net Income was 748 + 744 + 380 + 711 = $2,583 Mil.
Cash Flow from Operations was 1053 + 898 + 816 + 444 = $3,211 Mil.
Revenue was 5045 + 5001 + 5430 + 5059 = $20,535 Mil.
Gross Profit was 2661 + 2697 + 2894 + 2630 = $10,882 Mil.
Total Assets at the begining of this year (Jun13) was $47,503 Mil.
Total Assets was $46,734 Mil.
Long-Term Debt was $9,122 Mil.
Total Current Assets was $13,546 Mil.
Total Current Liabilities was $11,854 Mil.
Net Income was -452 + 630 + 320 + -79 = $419 Mil.

Revenue was 4924 + 4901 + 5249 + 4972 = $20,046 Mil.
Gross Profit was 2593 + 2590 + 2785 + 2601 = $10,569 Mil.
Total Assets at the begining of last year (Jun12) was $48,881 Mil.
Total Assets was $47,503 Mil.
Long-Term Debt was $9,925 Mil.
Total Current Assets was $14,091 Mil.
Total Current Liabilities was $12,835 Mil.

Profitability

Q1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Teva Pharmaceutical Industries Ltd's current net income was 2,583. ==> Positive ==> Score 1.

Q2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Teva Pharmaceutical Industries Ltd's current cash flow from operations was 3,211. ==> Positive ==> Score 1.

Q3. Change in Return on Assets

Compare this year’s return on assets (1) to last year’s return on assets.

Score 1 if it’s higher, 0 if it’s lower.

ROA (This Year)=Net Income/Total Assets at the beginning of this year (Jun13)
=2583/47503
=0.05437551

ROA (Last Year)=Net Income/Total Assets at the beginning of last year (Jun12)
=419/48881
=0.00857184

Teva Pharmaceutical Industries Ltd's return on assets of this year was 0.05437551. Teva Pharmaceutical Industries Ltd's return on assets of last year was 0.00857184. ==> This year is higher. ==> Score 1.

Q4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA =< ROA.

Teva Pharmaceutical Industries Ltd's current net income was 2,583. Teva Pharmaceutical Industries Ltd's current cash flow from operations was 3,211. ==> 3,211 > 2,583 ==> CFROA > ROA ==> Score 1.

Funding

Q5. Change in Gearing or Leverage

Compare this year’s gearing (long-term debt divided by average total assets) to last year’s gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year)=Long-Term Debt/Total Assets
=9122/46734
=0.1951898

Gearing (Last Year)=Long-Term Debt/Total Assets
=9925/47503
=0.20893417

Teva Pharmaceutical Industries Ltd's gearing of this year was 0.1951898. Teva Pharmaceutical Industries Ltd's gearing of last year was 0.20893417. ==> This year is lower or equal to last year. ==> Score 1.

Q6. Change in Working Capital (Liquidity)

Compare this year’s current ratio (current assets divided by current liabilities) to last year’s current ratio.

Score 1 if this year'’s current ratio is higher, 0 if it’s lower

Current Ratio (This Year)=Total Current Assets/Total Current Liabilities
=13546/11854
=1.14273663

Current Ratio (Last Year)=Total Current Assets/Total Current Liabilities
=14091/12835
=1.09785742

Teva Pharmaceutical Industries Ltd's current ratio of this year was 1.14273663. Teva Pharmaceutical Industries Ltd's current ratio of last year was 1.09785742. ==> This year's current ratio is higher. ==> Score 1.

Q7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Teva Pharmaceutical Industries Ltd's number of shares in issue this year was 857. Teva Pharmaceutical Industries Ltd's number of shares in issue last year was 849. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Q8. Change in Gross Margin

Compare this year’s gross margin (gross profit divided by sales) to last year’s.

Score 1 if this year’s gross margin is higher, 0 if it’s lower.

Gross Margin (This Year)=Gross Profit/Revenue
=10882/20535
=0.52992452

Gross Margin (Last Year)=Gross Profit/Revenue
=10569/20046
=0.52723735

Teva Pharmaceutical Industries Ltd's gross margin of this year was 0.52992452. Teva Pharmaceutical Industries Ltd's gross margin of last year was 0.52723735. ==> This year's gross margin is higher. ==> Score 1.

Q9. Change in asset turnover

Compare this year’s asset turnover (total sales divided by total assets at the beginning of the year) to last year’s asset turnover ratio.

Score 1 if this year’s asset turnover ratio is higher, 0 if it’s lower

Asset Turnover (This Year)=Revenue/Total Assets at the beginning of this year (Jun13)
=20535/47503
=0.43228849

Asset Turnover (Last Year)=Revenue/Total Assets at the beginning of last year (Jun12)
=20046/48881
=0.41009799

Teva Pharmaceutical Industries Ltd's asset turnover of this year was 0.43228849. Teva Pharmaceutical Industries Ltd's asset turnover of last year was 0.41009799. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score=Q1+Q2+Q3+Q4+Q5+Q6+Q7+Q8+Q9
=1+1+1+1+1+1+0+1+1
=8

Good or high score = 8 or 9

Bad or low score = 0 or 1

Teva Pharmaceutical Industries Ltd has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.


Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Net Income, Cash Flow from Operations, Revenue, Gross Profit, Total Assets, Long-Term Debt, Total Current Assets, Total Current Liabilities


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Q1 1111111111
Q2 1111111111
Q3 0101011000
Q4 1110111111
Q5 0001011001
Q6 0100010010
Q7 0100100111
Q8 1111101011
Q9 1010101000
F-score 5755667466

Teva Pharmaceutical Industries Ltd Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
Q1 1111111111
Q2 1111111111
Q3 0000000001
Q4 1111111111
Q5 0000011101
Q6 0111100011
Q7 1111111110
Q8 0001111111
Q9 1110000011
F-score 5666666678
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide